Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2000
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005471A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
06/07/2000EP1005463A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same
06/07/2000EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors
06/07/2000EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases
06/07/2000EP1005354A1 Peptide mimetics of the cytokine receptor gamma chain
06/07/2000EP1005345A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
06/07/2000EP1005342A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
06/07/2000EP0840606B1 Di- and trivalent small molecule selectin inhibitors
06/07/2000EP0633783B1 Rapamycin formulation for iv injection
06/07/2000CN1255863A Green porphyrins as immunomodulators
06/07/2000CN1255849A Medical compsns.
06/07/2000CN1053187C Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
06/06/2000US6072037 Antibodies to the IL-17 receptor
06/06/2000US6072035 Reshaped monoclonal antibodies against an immunoglobulin isotype
06/06/2000US6072033 Receptor that binds IL-17
06/06/2000US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071947 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
06/06/2000US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071905 Treating tuberculosis, mycobacteriosis, viral and immune diseases, chlamydia infections, antitumor and -carcinogenic agents; microbiocides, in particular to mycobacteria resistant to isoniazide; stimulantes interferons
06/06/2000US6071897 Use of vitamin D compounds to prevent transplant rejection
06/06/2000US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071721 Calcium binding protein
06/06/2000US6071522 Cloning of mite allergens
06/06/2000US6071519 Treating autoimmune diseases, hodgkin's disease and other lymph cancers
06/06/2000US6071517 Induction of effector-cell-mediated cytolysis; antitumor agents
06/06/2000US6071516 Administering normal gamma-globulin
06/06/2000US6071515 Dimer and multimer forms of single chain polypeptides
06/06/2000CA2206233C Combination dosage form comprising cetirizine and pseudoephedrine
06/02/2000WO2000031288A1 Method for screening cd14 agonist or antagonist
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031132A1 Novel polypeptide
06/02/2000WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000WO2000031065A1 Compounds having cytokine inhibitory activity
06/02/2000WO2000031060A1 Scavenger compounds
06/02/2000WO2000031053A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000031033A1 Piperidine ccr-3 receptor antagonists
06/02/2000WO2000030681A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000WO2000030679A1 Cd25 binding molecules for use in the treatment of manifestations of rejection in transplantation
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030667A2 Compositions and methods using lactadherin or variants thereof
06/02/2000WO2000030622A2 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
06/02/2000WO2000030616A1 Dispersible phospholipid stabilized microparticles
06/02/2000WO2000030615A1 Method of preparing stable suspensions of insoluble microparticles
06/02/2000WO2000030614A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state
06/02/2000WO2000030613A1 New process
06/02/2000WO2000013703A9 Methods of treating hypertension and compositions for use therein
06/02/2000WO2000008177A3 Death associated kinase containing ankyrin repeats (dakar)
06/02/2000WO2000007621A3 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent
06/02/2000WO2000007610A8 Interacting proteins for autoantigens of autoimmune diseases
06/02/2000WO1999061097A9 Alpha emitting constructs and uses thereof
06/02/2000CA2352963A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000CA2352458A1 Compositions and methods using lactadherin or variants thereof
06/02/2000CA2352347A1 Novel polypeptide
06/02/2000CA2352144A1 Scavenger compounds
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351631A1 Piperidine quaternary salts-ccr-3 receptor antagonists
06/02/2000CA2351630A1 Vector
06/02/2000CA2351361A1 Gtpase associated proteins
06/02/2000CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000CA2351065A1 Method for screening cd14 agonist or antagonist
06/02/2000CA2350969A1 Compounds having cytokine inhibitory activity
05/2000
05/31/2000EP1004664A1 Compositions and methods using lactadherin or variants thereof
05/31/2000EP1004598A2 Coated carrier materials for the purification of blood, plasma and tissues, and columns comprising said carrier materials
05/31/2000EP1004593A2 Backbone modified oligonucleotide analogues
05/31/2000EP1004584A2 Pyranoquinoline derivatives as inhibitors of cell proliferation
05/31/2000EP1004581A2 Process for the preparation of thalidomide
05/31/2000EP1004580A2 Imides as inhibitors of TNF alpha
05/31/2000EP1004578A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
05/31/2000EP1004572A2 Amines as inhibitors of TNF alpha
05/31/2000EP1004315A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient
05/31/2000EP1004312A1 Method for treating multiple sclerosis
05/31/2000EP1003861A2 Mammalian cell membrane proteins; related reagents
05/31/2000EP1003857A2 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003856A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
05/31/2000EP1003850A1 Inhibitors of dna immunostimulatory sequence activity
05/31/2000EP1003782A1 Ligand for herpes simplex virus entry mediator and methods of use
05/31/2000EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
05/31/2000EP1003770A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003768A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003743A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity
05/31/2000EP1003729A1 6-azauracil derivatives as il-5 inhibitors
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003560A1 Radioprotectant for peptides labeled with radioisotope
05/31/2000EP1003552A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
05/31/2000EP1003551A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
05/31/2000EP1003550A1 Receptor specific transepithelial transport of therapeutics
05/31/2000EP1003544A1 C1q AND COLLECTIN RECEPTOR
05/31/2000EP1003536A1 Immunostimulatory and metastasis inhibiting fermented vegetal material
1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 1172